TPWA
ONC

Twin Peaks Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2
Closed -$594 – 2334
2026
Q1 		$594 Buy
+2
New +$647 ﹤0.01% 2006
2025
Q3 		– Sell
-2
Closed -$576 – 2257
2025
Q2 		$576 Buy
+2
New +$490 ﹤0.01% 1881

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Twin Peaks Wealth Advisors's ONC Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 2 shares — an estimated $594 sold.

Twin Peaks Wealth Advisors first reported a position in ONC in Q2 2025 and held it in 2 quarters. The position peaked at $594 in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 2 BeOne Medicines Ltd shares in Q2 2026, an estimated $594.
  • Twin Peaks Wealth Advisors first reported a position in BeOne Medicines Ltd in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's BeOne Medicines Ltd position peaked at $594 in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.